Companies › TVGN
TEVOGEN BIO HOLDINGS INC (TVGN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001860871 · EDGAR filings · Updated 2026-07-23
TEVOGEN BIO HOLDINGS INC (TVGN) has 33 institutional managers reporting positions valued at $6.92M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-23 — PRE 14A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-14 — SCHEDULE 13D/A filed
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, TEVOGEN BIO HOLDINGS INC has 33 institutional holders.
Insider activity
Insiders reported 12 transactions (0 buys, 4 sells) across 4 reporting insiders, with a net reported value of −$1.78M.
Data flags from SEC filings
Related companies
NEUPHORIA THERAPEUTICS IN (NEUP) · Kyntra Bio Inc (KYNB) · CERVOMED INC (CRVO) · Lite Strategy Inc (LITS) · DarioHealth Corp (DRIO) · Traws Pharma Inc (TRAW)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.